2014-07-01 23:52:21 UTC

CGH Podcast July 2014: Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients

A “Perspectives in Clinical Gastroenterology and Hepatology” article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to first author Dr. Kathleen E. Corey of the Department of Medicine, Gastrointestinal Unit, Massachusetts General Hospital; Plus, summaries of top stories from this month's issue of GI and Hepatology News.

 

 

Corey KE, Chalasani N. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology & Hepatology 2014; July 12(7): 1077-1084
Abstract

 

 

Duration: 13.44m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

 

 

More on Non-Alcoholic Fatty Liver Disease (NAFLD)

What are the Effects of Prednisolone in Patients With Severe Alcoholic Liver Disease?

April 25, 2017

Infections are frequent, but only independently associated with mortality when patients receive prednisolone. More info on the AGA Journals Blog.

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

April 25, 2017

We identified 2 major subtypes of NAFLD and markers that differentiate steatosis from NASH in each subtype.

Liver & Biliary Sessions Scheduled at DDW® 2017

April 17, 2017

Council leadership hand-picked a preview of sessions for you to add to your DDW® itinerary.